Lauxera Capital Partners

Veranex is the first truly end-to-end, global, tech-enabled, concept-through-commercialization service provider that focuses solely on medical technology: medical device, diagnostics, companion diagnostics, digital health, and drug delivery. For all your needs through the entire medical device clinical trial process, Veranex is transforming medtech innovations.

Lifen is a healthcare data management platform that facilitates secure communication between health professionals. The company provides a mail assistant that generates secure medical email addresses, reduces paper mail costs, and automates the identification of available communication methods for correspondents. By streamlining medical communication, Lifen enables healthcare practitioners to share and analyze medical data efficiently and securely. The company operates in compliance with regulations and guidelines set by relevant authorities, acting as a subcontractor to physicians or healthcare facilities without owning the data it hosts.

Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.

Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.

LUMICKS B.V. is a company that specializes in the manufacture of dynamic single-molecule analysis equipment, enabling researchers to visualize biological processes at the molecular level. The company offers advanced systems such as the C-Trap, which integrates optical tweezers with confocal microscopy or STED nanoscopy, as well as microfluidics solutions for single-molecule experiments. Its Acoustic Force Spectroscopy (AFS) technology allows scientists to examine the mechanical properties of biological systems using synthetic microspheres. Additionally, LUMICKS provides the u-Flux microfluidics system, designed for conducting experiments in a laminar flow environment. Founded in 2014 and headquartered in Amsterdam, the Netherlands, LUMICKS also has an office in Cambridge, Massachusetts, and operates consumables stores to support its instrumentation offerings. The company focuses on delivering cutting-edge technologies for studying biology and cancer at the single-molecule and single-cell levels.

Reapplix A/S manufactures device for cell therapy that helps patients in wound healing. It offers 3C Patch, a triple layer patch that consists of fibrin for moisture retention and strength, platelets for growth factor release, and leucocytes to orchestrate wound healing and to fight infection. The company was formerly known as Reapplix ApS and changed its name to Reapplix A/S in December 2018. Reapplix A/S was founded in 2008 and is based in Birkerød, Denmark with an additional office in Southlake, Texas.